Low AS160 and high SGK basal phosphorylation associates with impaired incretin profile and type 2 diabetes in adipose tissue of obese patients
Obesity and related metabolic disorders, including type 2 diabetes mellitus (T2DM), alarmingly grow up in the modern society thus representing a serious issue for endocrinology and medicine. Obesity is the major risk factor for T2DM [1], however, not all obese individuals ultimately develop T2DM. Nevertheless, mechanisms linking obesity to T2DM are being extensively studied.
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Iurii S. Stafeev, Igor A. Sklyanik, Kamil A. Yah'yaev, Ekaterina A. Shestakova, Anatoly V. Yurasov, Andrey V. Karmadonov, Alexander V. Chibalin, Mikhail Yu. Menshikov, Alexander V. Vorotnikov, Yelena V. Parfyonova, Marina V. Shestakova Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Incretin Therapy | Men | Obesity